Teladoc Health trading on the story, not the valuation, says Gilman's Jenny Harrington

Jenny Harrington, Gilman Hill Asset Management CEO, joins 'Halftime Report' to discuss the falling Teladoc shares and the pressure the ARK Innovation ETF in facing right now.